Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3193278 | Annals of Allergy, Asthma & Immunology | 2007 | 5 Pages |
Abstract
Although AIT is a safe and effective immunomodulatory therapeutic option for the treatment of allergic diseases, patients with increased frequency of large local reactions may have increased risk for future systemic reactions. Identifying additional risk factors remains viable. Recognizing the relevance of frequent large local reactions is important for designing safer protocols for successful AIT in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Sitesh R. MD, Justin R. BS, Jake PhD, John E. MD, David A. MD, Gailen D. MD, PhD,